Ticker: HBIO

Harvard Bioscience, Inc. (NASDAQ: HBIO) - Q1 2025 Company Update Financial Overview: Revenues: $21.8 million (down 11.2% from $24.5 million in Q1 2024) Gross Profit: $12.2 million (decreased by 17.5%, gross margin at 56.0%) Operating Loss: $(49.7) million, a significant increase from $(2.3) mill...